These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 704645)

  • 1. [Evaluation of the topical bioavailability of hydrocortisone acetate].
    Aiache JM; Ducroux P
    Pharm Acta Helv; 1978; 53(3-4):110-20. PubMed ID: 704645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recovery rate of externally administered glucocorticoids on the skin surface].
    Wohlrab W
    Dermatol Monatsschr; 1986; 172(10):615-9. PubMed ID: 3803661
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability of hydrocortisone acetate from ophthalmic ointments.
    Umer S
    Acta Pol Pharm; 1994; 51(1):39-43. PubMed ID: 7976432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of urea and lactic acid on the percutaneous absorption of hydrocortisone.
    Wahlberg JE; Swanbeck G
    Acta Derm Venereol; 1973; 53(3):207-10. PubMed ID: 4124013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of the effect of formulation on the bioavailability of topical corticoids by non-contact reflectometry].
    Le Gall F; Levèque JL; Poelman MC
    Pharm Acta Helv; 1985; 60(4):125-8. PubMed ID: 4011625
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiinflammatory activity and bioavailability of percutaneous piroxicam.
    Schiantarelli P; Cadel S; Acerbi D; Pavesi L
    Arzneimittelforschung; 1982; 32(3):230-5. PubMed ID: 7200781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of proprietary corticosteroid containing ointments.
    Trikam DS; Morton DJ
    Cent Afr J Med; 1985 Mar; 31(3):57-8. PubMed ID: 4016908
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical glucocorticosteroids.
    Fritz KA; Weston WL
    Ann Allergy; 1983 Feb; 50(2):68-76. PubMed ID: 6337530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the biologic availability of preparations for topical use by experimental dermatologic methods].
    Murav'ev IA; Mar'iasis ED; Starokozhko LE; Chebotarev VV; Krasova TG
    Farmatsiia; 1977; 26(4):15-9. PubMed ID: 902786
    [No Abstract]   [Full Text] [Related]  

  • 10. [The penetration of drugs into the skin].
    Schaefer H; Zesch A; Stüttgen G
    Hautarzt; 1975 Sep; 26(9):449-51. PubMed ID: 1102493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absorption of af 2071 (hydrocortisone-bendazac ester) after topical application compared with oral administration].
    Catanese B; Barillari G; Rossi V
    Boll Chim Farm; 1978 Jun; 117(6):368-74. PubMed ID: 743382
    [No Abstract]   [Full Text] [Related]  

  • 12. A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations.
    Schoenwald RD; Boltralik JJ
    Invest Ophthalmol Vis Sci; 1979 Jan; 18(1):61-6. PubMed ID: 759386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of superoxide dismutase: implications for the anti-inflammatory action mechanism of orgotein.
    Huber W; Menander-Huber KB; Saifer MG; Williams LD
    Agents Actions Suppl; 1980; 7():185-95. PubMed ID: 6454334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraarticular injection of hydrocortisone after experimental radical reconstructive surgery].
    Myrzak EP; Khaĭdarly IN
    Probl Tuberk; 1966; 44(5):77-82. PubMed ID: 5993156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measurement of corticosteroids topical availability by thermography (author's transl)].
    Aiache JM; Lafaye C; Bouzat J; Rabier R
    J Pharm Belg; 1980; 35(3):187-95. PubMed ID: 7400923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Animal experiment studies on the epidermal-hypoplastic effects of topical corticoids].
    Weirich EG; Longauer J
    Arztl Forsch; 1971 Sep; 25(9):292-8. PubMed ID: 5171203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ultraphonophoresis and its effect on the distribution and deposition of hydrocortisone 4-C-14 in experiments].
    Gatev SP; Pantev GP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(1):42-5. PubMed ID: 5456680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of drug availability from commercial topical formulations with a multilayer membrane model].
    Neubert R; Winter K; Bendas B
    Pharmazie; 1993 Jan; 48(1):54-6. PubMed ID: 8460175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig.
    Aldridge RD; Thomson AW; Rankin R; Whiting PH; Cunningham C; Simpson JG
    Clin Exp Immunol; 1985 Jan; 59(1):23-8. PubMed ID: 3971598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.